Developing Acid‐Responsive Glyco‐Nanoplatform Based Vaccines for Enhanced Cytotoxic T‐lymphocyte Responses Against Cancer and SARS‐CoV‐2-Reference-Cited by-同舟云学术

Developing Acid‐Responsive Glyco‐Nanoplatform Based Vaccines for Enhanced Cytotoxic T‐lymphocyte Responses Against Cancer and SARS‐CoV‐2

Published:2021-07-17 Issue:41 Volume:31 Page:2105059
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Gao Yanan¹,Zhao Qingyu¹,Dong Huiling¹,Xiao Min¹,Huang Xuefei²^ORCID,Wu Xuanjun¹³^ORCID

Affiliation:

1. National Glycoengineering Research Center Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate‐Based Medicine Shandong University Qingdao Shandong 266237 China

2. Departments of Chemistry and Biomedical Engineering Institute for Quantitative Health Science and Engineering Michigan State University East Lansing MI 48824 USA

3. Suzhou Research Institute Shandong University Suzhou Jiangsu 215123 China

Funder

Natural Science Foundation of Shandong Province

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Shandong University

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials